Full Text View
Tabular View
Study Results
Related Studies
Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)
This study has been terminated.
( More than 2 of 6 patients treated experienced dose limiting toxicities. )
Study NCT01400451   Information provided by Bristol-Myers Squibb

First Received on July 21, 2011.   Last Updated on May 19, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial